Therapeutic Potential of Kappa-Opioids Against Cocaine - 1

Completed

• Conditions: Cocaine-Related Disorders

• Registration Number: NCT00000323
• Lead Sponsor: National Institute on Drug Abuse (NIDA)

Brief Summary

The purpose of this study is to characterize the effects of enadoline compared to hydromorphone and butorphanol.

Detailed Description

Not available

Study Timeline

• Study Start: 1996-07
• Study Completion: 1998-12
• Study First Submitted: 1999-09-20
• Study First Submitted QC: 1999-09-20
• Study First Posted: 1999-09-21
• Status Verified: 2004-05
• Last Update Submitted: 2017-01-11
• Last Update Posted: 2017-01-12

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

opiate experienced, healthy

Exclusion Criteria

physical dependence on opioids, barbiturates or alcohol

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

Johns Hopkins University (BPRU) Bayview Campus; 🇺🇸 Baltimore, Maryland, United States